A broken heart courtesy of the flu
Apparently, the flu can break more than your weekly plans—it can break your heart, too. In a case report published in Cureus, physicians described a 67-year-old woman who developed Takotsubo cardiomyopathy, better known as broken heart syndrome, following an influenza A infection. She initially arrived at the emergency department with cough, body aches, back pain, chest pain, and gastrointestinal distress. A rapid test confirmed influenza A, and she was sent home with oseltamivir. But 2 weeks later, she returned with something far more alarming: episodes of exertional chest pain and shortness of breath, followed by sudden chest pain radiating down her left arm. Her heart was signaling serious trouble. An ECG revealed widespread T-wave inversions, and troponin I peaked at 1.4 ng/mL. An echocardiogram showed severely reduced left ventricular function, with an ejection fraction of just 30%. Despite putting on a convincing acute coronary syndrome impersonation, cardiac catheterization revealed nonobstructive coronary artery disease. Left ventriculography cleared up the mystery, demonstrating severe apical hypokinesis with hyperdynamic basal segments—classic features of Takotsubo cardiomyopathy. Initially treated with aspirin, clopidogrel, and intravenous heparin, she was subsequently prescribed a statin and an angiotensin-converting enzyme inhibitor before discharge with prompt cardiology follow-up. While full recovery typically occurs within 3 to 4 weeks, potential complications include heart failure, cardiogenic shock, arrhythmias, and thrombosis. Apparently, the flu can leave a lasting impression—even after the coughing has stopped.
Source: Cureus
Frozen hair follicles make a comeback
Who knew hair follicles could survive a deep freeze and still have a little growing left to do? In a study published in Scientific Reports, researchers at Yokohama National University in Japan explored whether human hair follicles could be frozen, thawed, and coaxed back into action, potentially giving hair loss research a cool upgrade. The team collected scalp follicles from men with androgenetic alopecia undergoing hair transplantation and compared 2 preservation methods: slow freezing and vitrification, a rapid-freezing technique using liquid nitrogen. After at least 1 week in liquid nitrogen, the follicles were thawed and cultured for 7 days. The results? Slow freezing was a bit of a follicular disaster, producing extensive cell death and severely limiting hair shaft elongation. Vitrification, however, kept things growing, with follicles achieving approximately 75% of the elongation observed in fresh samples. Cell viability was also substantially better, although neither method escaped damage entirely. But there was a hairy complication: both approaches accelerated the transition from anagen, the active growth phase, to catagen, the regression phase. Vitrified follicles generally reached earlier catagen stages, while slow-frozen follicles progressed further into regression. Researchers then gave the vitrified follicles a familiar helping hand: minoxidil. At 10 μM, minoxidil helped maintain hair shaft elongation and significantly improved hair cycle scores compared with untreated controls. Although these findings suggest a promising model for testing treatments, the study involved only follicles from men with androgenetic alopecia, and the protocols differed in both cooling rates and chemical compositions. No human hair regrowth was tested, but these follicles certainly weren't ready to retire after their icy vacation.
Source: Scientific Reports
Dreams may spill mental health secrets
Ever wonder what your brain gets up to when you're not paying attention? Turns out, all that mental wandering might be revealing more than you'd expect. In a recently published study, researchers explored whether the language people use to describe their daydreams and dreams reflects their mental health. They analyzed 1,496 mind-wandering reports from 152 adults and 1,781 dream reports from 172 adults, aged 19 to 78 years, in Australia and the United Kingdom. Over 2 weeks in 2020, participants spent 10 minutes each evening letting their thoughts drift before writing down whatever came to mind. Their morning homework? Jotting down their dreams. Using linguistic analysis software, researchers found that people reporting greater anxiety, depressive symptoms, and negative affect tended to use more words associated with fear, anger, and sadness during mind-wandering. Anxiety symptoms and negative affect showed particularly strong associations, while depression was linked to nearly every negative emotion category except anger. Dreams were a little harder to read. Greater negative affect was associated with more anxiety-related language, although the finding weakened when shorter reports were excluded. Meanwhile, greater peace of mind and psychological well-being were associated with more positive language during mind-wandering, but those results didn't consistently hold up under additional analyses. The observational study had limitations, including pandemic-era data collection, a predominantly female sample, and software that couldn't quite grasp sarcasm or negation. Apparently, the brain has plenty to say, even when nobody's listening.
Source: Neuroscience of Consciousness
Is matcha a brain booster?
Could a matcha latte be giving the brain a little extra pep, or is it just another trendy drink with excellent public relations? Researchers at Taipei Medical University decided to spill the tea in a systematic review and meta-analysis examining whether matcha consumption could sharpen cognitive function. After screening 113 records, they identified 4 double-blind randomized controlled trials conducted in Japan involving 229 adults, ranging from healthy young adults to older adults with cognitive concerns. Participants consumed 2 to 3 g of matcha daily for 2 weeks to 12 months, providing approximately 170 to 277 mg of catechins, 48 to 50 mg of L-theanine, and 66 to 81 mg of caffeine. The results? A mixed bag of brain-boosting possibilities. Although most trials found no significant improvements in overall cognition, an exploratory pooled analysis suggested better Montreal Cognitive Assessment scores among matcha drinkers. However, Mini-Mental State Examination scores showed no significant benefit. Interestingly, women in one trial demonstrated improved language performance, while younger adults showed faster attention-related responses following mild psychological stress. Another trial found improved social acuity among older adults with cognitive concerns, while middle-aged participants maintained cognitive scores over 12 weeks as placebo recipients experienced declines. Matcha's potential neurological perks may involve its antioxidant-rich catechins, L-theanine, and caffeine, although the mechanisms remain unconfirmed. With only 4 small trials, varying cognitive assessments, and limited long-term follow-up, the evidence remains inconclusive. The bottom line? Matcha shows some promise, but its brain-boosting credentials are still steeping.
Source: Journal of Epidemiology
The intersection of medicine and the unexpected reminds us how wild, weird, and wonderful science can be. The world of health care continues to surprise and astonish.
